IgM Antibodies Targeting Malondialdehyde Promote Complement‐Mediated Liver Injury in Alcohol‐Related Liver Disease
Liver International · 2025
DOI: 10.1111/liv.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Dragana Rajcic und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Immunoglobulin M, Liver Diseases, Alcoholic, Malondialdehyde. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background and Aims Alcohol‐related liver disease (ALD) is associated with elevated blood immunoglobulin‐type M (IgM) levels and hepatic lipid peroxidation. Nevertheless, the functional relevance of systemic IgM targeting lipid peroxidation products during ALD is incompletely understood.
Methods
Levels of IgM and IgG recognising malondialdehyde–acetaldehyde (MAA), as a hallmark epitope of lipid peroxidation, as well as complement factors were assessed in the serum of patients with ALD. The influence of alcohol abstinence on anti‐MAA IgM and IgG levels was determined in AUD patients. A chronic‐binge ethanol diet was given to mice deficient in sialic acid‐binding immunoglobulin‐like lectin G ( Siglec‐G −/− ), with specifically increased systemic IgM, and mice lacking soluble IgM ( sIgM −/− ), and their corresponding littermates. Furthermore, wildtype mice were injected with MAA‐binding IgM antibodies (LR04) or isotype control IgM during chronic‐binge ethanol feeding. Siglec‐G −/− bone marrow transplantation into wildtype or complement C3 deficient mice ( C3 −/− ) was performed to investigate the involvement of complement activation by elevated IgM in ALD.
Results
Serum levels of anti‐MAA IgM positively correlated with ALD severity in humans. While mice lacking soluble IgM had less pronounced liver injury, increased circulating anti‐MAA IgM titers in Siglec‐G −/− mice associated with more hepatocellular damage after ethanol feeding than wildtypes. Similarly, mice receiving LR04 displayed elevated liver injury compared to control‐injected mice. Moreover, besides less hepatic neutrophil and macrophage content, and stellate cell activation than wildtypes, ethanol‐fed Siglec‐G −/− and LR04‐treated mice had increased hepatic C3b deposition. Mice deficient in C3 displayed ameliorated ethanol‐induced liver injury compared with controls, despite similarly high anti‐MAA IgM levels after Siglec‐G −/− bone marrow transplantation, suggesting complement‐dependent liver injury upon high anti‐MAA IgM. In line, levels of MAA‐binding IgM inversely correlated with C3c and C4 in serum of patients with ALD.
Conclusion
Elevated systemic IgM titres that recognise MDA facilitate complement recruitment, which enhances hepatocyte injury, thereby promoting alcohol‐associated liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
- Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
- Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
- Psychosocial Health Center ESRA, Vienna, Austria.
ORCID-Profile: Dragana Rajcic, Beatriz Pereira da Silva, Benedikt Simbrunner, Benedikt S Hofer, Mattias Mandorfer, Thomas Reiberger
Förderung
- Austrian Science Fund
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Rajcic, D., da Silva, B. P., Baranovskyi, T., Simbrunner, B., Hofer, B. S., Hoebinger, C., Duckova, T., Papac-Milicevic, N., Listabarth, S., Weber, S., Vyssoki, B., König, D., Burger, K., Bergheim, I., Binder, C. J., Mandorfer, M., Reiberger, T., & Hendrikx, T. (2025). IgM Antibodies Targeting Malondialdehyde Promote Complement‐Mediated Liver Injury in Alcohol‐Related Liver Disease. Liver International. https://doi.org/10.1111/liv.70356
Vancouver
Rajcic D, da Silva BP, Baranovskyi T, Simbrunner B, Hofer BS, Hoebinger C, et al. IgM Antibodies Targeting Malondialdehyde Promote Complement‐Mediated Liver Injury in Alcohol‐Related Liver Disease. Liver International. 2025. doi:10.1111/liv.70356
BibTeX
@article{Rajcic2025,
author = {Rajcic, Dragana and da Silva, Beatriz Pereira and Baranovskyi, Taras and Simbrunner, Benedikt and Hofer, Benedikt S and Hoebinger, Constanze and Duckova, Tereza and Papac-Milicevic, Nikolina and Listabarth, Stephan and Weber, Sabine and Vyssoki, Benjamin and König, Daniel and Burger, Katharina and Bergheim, Ina and Binder, Christoph J and Mandorfer, Mattias and Reiberger, Thomas and Hendrikx, Tim},
title = {IgM Antibodies Targeting Malondialdehyde Promote Complement‐Mediated Liver Injury in Alcohol‐Related Liver Disease},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70356}
}
EUVIMED